Company: OFIX
Filing Date: 2025-02-25
Form Type: S-3ASR
Source: 0000950170-25-026634
Chunk: 38

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: S-3ASR
Chunk 38
---
8*        | Form of Unit Agreement.                                                                                                                                       |
| 5.1         | Opinion of Hogan Lovells US LLP.                                                                                                                              |
| 23.1        | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm for Orthofix Medical Inc.                                                         |
| 23.2        | Consent of Hogan Lovells US LLP (included in Exhibit 5.1).                                                                                                    |
| 24.1        | Power of Attorney (included on signature page).                                                                                                               |
| 25.1*       | Form T-1 Statement of Eligibility and Qualification under the Trust Indenture Act of 1939 of Trustee for Form of Indenture.                                   |
| 107         | Filing Fee Table.                                                                                                                                             |

| * | To be filed, if necessary, as an exhibit to a post-effective amendment to this registration statement or as an exhibit to a Current Report on Form 8-K to be filed by the registrant in connection with a specific offering, and incorporated herein by reference. |

<div align='center'>II-4</div>

Item 17. Undertakings.

The undersigned registrant hereby undertakes:

To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change set forth in the information in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided, however, that paragraphs (i), (ii) and (iii) do not apply if the information required to be included in a